GPT and neutropenia: Occurrence of laboratory AEs, e.g. neutropenia (DHA-PQP: 18/1038, 1.7%; AL: 12/510, 2.4%) and altered liver enzymes (ALT) (DHA-PQP: 20/1038, 1.9%; AL: 19/510, 3.7%), was similar between the two treatment groups.